🔴 HIMS is trading 5% down today as investors weigh AI Labs launch

HIMS is trading at $25.48 (-5.23%) following the launch of Labs AI as investors question whether the company's AI healthcare ambitions justify the recent hype.

• Wall Street appears skeptical of the new AI product reveal just four days before the company's scheduled earnings report.
• The stock is significantly underperforming the broader market, with the S&P 500 down only 0.31%.
• Shares fell through the $25.79 level earlier in the session amid high volatility surrounding the company's AI healthcare strategy.